Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
39 studies found for:    Open Studies | "Testicular Neoplasms"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Swiss Austrian German Testicular Cancer Cohort Study - SAG TCCS
Condition: Testicular Neoplasms
Intervention:
2 Recruiting Testicular Cancer and Aerobic and Strength Training
Condition: Testicular Neoplasms
Interventions: Behavioral: Exercise group;   Behavioral: Control group
3 Recruiting Shared Care Follow-up After Chemotherapy for Testicular Cancer
Condition: Testicular Cancer
Intervention:
4 Recruiting Health Status and Burden of Late Effects in Very Long-term Testicular Cancer Survivors (STANDBY-study)
Condition: Testicular Cancer
Intervention:
5 Recruiting Cause of Familial Testicular Cancer
Condition: Testicular Cancer
Intervention:
6 Recruiting The Platinum Study Comparison Group
Condition: Testicular Neoplasms
Intervention: Behavioral: Questionnaire
7 Recruiting Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer
Conditions: Testicular Neoplasms;   Seminoma
Interventions: Drug: Bleomycin Etoposide and Cisplatin;   Drug: Carboplatin
8 Recruiting Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer
Condition: Testicular Cancer
Interventions: Drug: Veliparib;   Drug: Gemcitabine;   Drug: Carboplatin
9 Recruiting Vascular Fingerprint Validation Study
Condition: Testicular Cancer
Intervention:
10 Recruiting TACkLE Study - Tackling Adverse Chemotherapy-associated Late Effects
Condition: Testicular Cancer
Intervention: Other: Vena punction
11 Recruiting Germ Cell Tumor and Testicular Tumor DNA Registry
Conditions: Germ Cell Tumor;   Testicular Tumor
Interventions: Behavioral: Questionnaires;   Other: sample of blood or saliva
12 Recruiting Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer
Condition: Testicular Cancer
Intervention: Drug: cabazitaxel
13 Recruiting Quality of Life Among Testicular Cancer Survivors
Conditions: Testicular Neoplasms;   Spermatic Cord Torsion;   Varicocele;   Testicular Hydrocele
Interventions: Other: Questionnaires;   Other: Hormonal Function measurement
14 Recruiting High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors
Condition: Testicular Cancer
Interventions: Drug: Gemcitabine;   Drug: Docetaxel;   Drug: Melphalan;   Drug: Carboplatin;   Drug: Mesna;   Drug: Ifosfamide;   Drug: Etoposide;   Procedure: Stem Cell Transplant
15 Recruiting Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy
Conditions: Peripheral Nervous System Diseases;   Testicular Neoplasms
Interventions: Procedure: Blood sample collection;   Behavioral: Report of peripheral neuropathy after cisplatin therapy
16 Recruiting Effectiveness of an Individualized Program of Muscular Strength and Endurance Program for Improving Germ Cell Cancer
Condition: Testicular Germ Cell Cancer
Intervention: Device: Aerobic program
17 Recruiting Knowledge and Attitudes Regarding Healthy Lifestyle and Health Behavior Change in Cancer Patients and Their Partners; A Pilot Study
Conditions: Breast Cancer;   Testicular Cancer
Intervention: Other: Literature search and semi-structured interview
18 Recruiting Autologous Dendritic Cell Vaccine Loaded With Allogeneic Tumor Lysate Expression of Cancer Testis Antigens in Patients With Soft Tissue Sarcoma
Conditions: Sarcoma;   Neoplasms, Connective and Soft Tissue
Intervention: Biological: Autologous dendritic cell vaccine
19 Recruiting Trial to Evaluate Progression Free Survival With Primary Retroperitoneal Lymph-node Dissection (pRPLND) Only in Patients With Seminomatous Testicular Germ Cell Tumors With Clinical Stage IIA/B (PRIMETEST)
Condition: Stage II A/B Seminomatous Germ Cell Tumors
Intervention: Procedure: Primary retroperitoneal lymph-node dissection (pRPLND)
20 Recruiting Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy
Conditions: Non-seminomatous Germ Cell Tumors;   Metastasis
Interventions: Other: K5-RGD PET;   Other: FDG

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.